id ftpubmed:oai:pubmedcentral.nih.gov:5632122
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:5632122 2023-05-15T16:45:36+02:00 Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland Gottfredsson, Magnus Tyrfingsson, Thorarinn Runarsdottir, Valgerdur Bergmann, Ottar M Bjornsson, Einar S Johannsson, Birgir Sigurdardottir, Bryndis Fridriksdottir, Ragnheidur H Löve, Arthur Löve, Thorvardur J Sigmundsdottir, Gudrun Heimisdottir, Maria Olafsson, Sigurdur 2017-10-04 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632122/ https://doi.org/10.1093/ofid/ofx162.101 en eng Oxford University Press http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632122/ http://dx.doi.org/10.1093/ofid/ofx162.101 © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com CC-BY-NC-ND Abstracts Text 2017 ftpubmed https://doi.org/10.1093/ofid/ofx162.101 2017-11-12T01:06:36Z Text Iceland PubMed Central (PMC) Open Forum Infectious Diseases 4 suppl_1 S42 S42
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Abstracts
spellingShingle Abstracts
Gottfredsson, Magnus
Tyrfingsson, Thorarinn
Runarsdottir, Valgerdur
Bergmann, Ottar M
Bjornsson, Einar S
Johannsson, Birgir
Sigurdardottir, Bryndis
Fridriksdottir, Ragnheidur H
Löve, Arthur
Löve, Thorvardur J
Sigmundsdottir, Gudrun
Heimisdottir, Maria
Olafsson, Sigurdur
Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland
topic_facet Abstracts
format Text
author Gottfredsson, Magnus
Tyrfingsson, Thorarinn
Runarsdottir, Valgerdur
Bergmann, Ottar M
Bjornsson, Einar S
Johannsson, Birgir
Sigurdardottir, Bryndis
Fridriksdottir, Ragnheidur H
Löve, Arthur
Löve, Thorvardur J
Sigmundsdottir, Gudrun
Heimisdottir, Maria
Olafsson, Sigurdur
author_facet Gottfredsson, Magnus
Tyrfingsson, Thorarinn
Runarsdottir, Valgerdur
Bergmann, Ottar M
Bjornsson, Einar S
Johannsson, Birgir
Sigurdardottir, Bryndis
Fridriksdottir, Ragnheidur H
Löve, Arthur
Löve, Thorvardur J
Sigmundsdottir, Gudrun
Heimisdottir, Maria
Olafsson, Sigurdur
author_sort Gottfredsson, Magnus
title Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland
title_short Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland
title_full Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland
title_fullStr Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland
title_full_unstemmed Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland
title_sort treatment as prevention for hepatitis c (trap hepc). a real-world experience from the first 12 months of a nationwide elimination program in iceland
publisher Oxford University Press
publishDate 2017
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632122/
https://doi.org/10.1093/ofid/ofx162.101
genre Iceland
genre_facet Iceland
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632122/
http://dx.doi.org/10.1093/ofid/ofx162.101
op_rights © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
http://creativecommons.org/licenses/by-nc-nd/4.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
op_rightsnorm CC-BY-NC-ND
op_doi https://doi.org/10.1093/ofid/ofx162.101
container_title Open Forum Infectious Diseases
container_volume 4
container_issue suppl_1
container_start_page S42
op_container_end_page S42
_version_ 1766035764217380864